NO942552L - Humanproteaseinhibitorvarianter av Kunitz-type - Google Patents
Humanproteaseinhibitorvarianter av Kunitz-typeInfo
- Publication number
- NO942552L NO942552L NO942552A NO942552A NO942552L NO 942552 L NO942552 L NO 942552L NO 942552 A NO942552 A NO 942552A NO 942552 A NO942552 A NO 942552A NO 942552 L NO942552 L NO 942552L
- Authority
- NO
- Norway
- Prior art keywords
- cys
- amino acid
- naturally occurring
- light
- acid residues
- Prior art date
Links
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 title abstract 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 5
- LBFYTUPYYZENIR-GHCJXIJMSA-N Asp-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N LBFYTUPYYZENIR-GHCJXIJMSA-N 0.000 abstract 1
- BWJZSLQJNBSUPM-FXQIFTODSA-N Asp-Pro-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O BWJZSLQJNBSUPM-FXQIFTODSA-N 0.000 abstract 1
- 102000012432 Collagen Type V Human genes 0.000 abstract 1
- 108010022514 Collagen Type V Proteins 0.000 abstract 1
- TUTIHHSZKFBMHM-WHFBIAKZSA-N Glu-Asn Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O TUTIHHSZKFBMHM-WHFBIAKZSA-N 0.000 abstract 1
- PKYAVRMYTBBRLS-FXQIFTODSA-N Glu-Cys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O PKYAVRMYTBBRLS-FXQIFTODSA-N 0.000 abstract 1
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 abstract 1
- KCFKKAQKRZBWJB-ZLUOBGJFSA-N Ser-Cys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O KCFKKAQKRZBWJB-ZLUOBGJFSA-N 0.000 abstract 1
- GDPDVIBHJDFRFD-RNXOBYDBSA-N Trp-Tyr-Tyr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GDPDVIBHJDFRFD-RNXOBYDBSA-N 0.000 abstract 1
- HIINQLBHPIQYHN-JTQLQIEISA-N Tyr-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HIINQLBHPIQYHN-JTQLQIEISA-N 0.000 abstract 1
- CWSIBTLMMQLPPZ-FXQIFTODSA-N Val-Cys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)N CWSIBTLMMQLPPZ-FXQIFTODSA-N 0.000 abstract 1
- 108010087924 alanylproline Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 108010003700 lysyl aspartic acid Proteins 0.000 abstract 1
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Variant av det C-terminale proteaseinhibitorområde av Kunitz-type i o3-kjeden i humant type Vl-kollagen, hvor varianten omfatter aminosyresek- vensen (I) X1 Asp Ile Cys Lys Leu Pro Lys Asp X2 Gly X3 Cys X4 X* X6 X7 X8 X9 Trp Tyr Tyr Asp Pro Asn Thr Lys Ser Cys Ala Arg Phe X10 Tyr Gly Gly Cys X11 X12 X13 Glu Asn Lys Phe X14 Ser Gin Lys Glu Cys Glu Lys Val Cys Ala Pro X15, hvor X1 er H eller 1-5 naturlig forekommende aminosyrerester bortsett fra Cys, X2-X14 hver uavhengig av hverandre er en naturlig forekommende aminosyrerest, og X15 er OH eller 1-5 naturlig forekomm- ende aminosyrerester bortsett fra Cys, med det forbehold at minst en av amino- syrerestene XJ-X15 er forskjellig fra den tilsvarende aminosyrerest i den naturlig forekommende sekvens.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK9200005 | 1992-01-07 | ||
| PCT/DK1993/000002 WO1993014119A1 (en) | 1992-01-07 | 1993-01-07 | Human kunitz-type protease inhibitor variants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942552D0 NO942552D0 (no) | 1994-07-06 |
| NO942552L true NO942552L (no) | 1994-09-07 |
Family
ID=8153776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942552A NO942552L (no) | 1992-01-07 | 1994-07-06 | Humanproteaseinhibitorvarianter av Kunitz-type |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5629176A (no) |
| EP (1) | EP0621869B1 (no) |
| JP (1) | JPH07506334A (no) |
| AT (1) | ATE152129T1 (no) |
| AU (1) | AU671611B2 (no) |
| CA (1) | CA2127248A1 (no) |
| CZ (1) | CZ164694A3 (no) |
| DE (1) | DE69310141D1 (no) |
| FI (1) | FI943231A (no) |
| HU (1) | HUT70292A (no) |
| IL (1) | IL104327A0 (no) |
| NO (1) | NO942552L (no) |
| NZ (1) | NZ246567A (no) |
| RU (1) | RU94036776A (no) |
| WO (1) | WO1993014119A1 (no) |
| ZA (1) | ZA9398B (no) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060134087A1 (en) * | 1988-09-02 | 2006-06-22 | Dyax Corp. | ITI-D1 Kunitz domain mutants as hNE inhibitors |
| US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| US5795954A (en) * | 1994-03-04 | 1998-08-18 | Genentech, Inc. | Factor VIIa inhibitors from Kunitz domain proteins |
| CA2220497A1 (en) * | 1995-05-08 | 1996-11-14 | Scios, Inc. | Kunitz type protease inhibitors |
| ZA963619B (en) | 1995-05-08 | 1996-11-22 | Scios Inc | Protease inhibitor peptides |
| US5780265A (en) * | 1995-06-05 | 1998-07-14 | Genentech, Inc. | Kunitz type plasma kallikrein inhibitors |
| US5786328A (en) * | 1995-06-05 | 1998-07-28 | Genentech, Inc. | Use of kunitz type plasma kallikrein inhibitors |
| US6242414B1 (en) | 1995-06-07 | 2001-06-05 | Chiron Corporation | Regulation of cytokine synthesis and release |
| US5736364A (en) * | 1995-12-04 | 1998-04-07 | Genentech, Inc. | Factor viia inhibitors |
| ATE477020T1 (de) | 2002-06-07 | 2010-08-15 | Dyax Corp | Prevention und verringerung von ischemia |
| US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
| DE602004031589D1 (de) * | 2003-01-07 | 2011-04-14 | Dyax Corp | Kunitz-domäne-bibliothek |
| US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| SI1981519T1 (en) | 2005-12-29 | 2018-05-31 | Dyax Corp. | INHIBITION PROTEAZE |
| WO2009026334A2 (en) * | 2007-08-21 | 2009-02-26 | Genzyme Corporation | Treatment with kallikrein inhibitors |
| DK2379096T3 (da) | 2008-12-19 | 2019-11-25 | Baxalta GmbH | TFPI-inhibitorer og fremgangsmåder til anvendelse |
| US8450275B2 (en) | 2010-03-19 | 2013-05-28 | Baxter International Inc. | TFPI inhibitors and methods of use |
| AU2010203712A1 (en) * | 2009-01-06 | 2010-07-15 | Dyax Corp. | Treatment of mucositis with kallikrein inhibitors |
| JP6037841B2 (ja) * | 2010-01-06 | 2016-12-07 | ダイアックス コーポレーション | 血漿カリクレイン結合タンパク質 |
| AU2012204202A1 (en) | 2011-01-06 | 2013-07-11 | Dyax Corp. | Plasma kallikrein binding proteins |
| HUE046572T2 (hu) | 2012-03-21 | 2020-03-30 | Baxalta GmbH | TFPI inhibitorok és alkalmazási eljárások |
| US10428158B2 (en) | 2014-03-27 | 2019-10-01 | Dyax Corp. | Compositions and methods for treatment of diabetic macular edema |
| CN108602893A (zh) | 2015-12-11 | 2018-09-28 | 戴埃克斯有限公司 | 血浆激肽释放酶抑制剂及其治疗遗传性血管性水肿发作的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3912638A1 (de) * | 1989-04-18 | 1990-10-31 | Bayer Ag | Gentechnologisch hergestellte homologe des alzheimer protease inhibitors, wirtstaemme sowie expressionsvektoren fuer ihre herstellung und ihre verwendung als arzneimittel |
| EP0401508B1 (de) * | 1989-05-13 | 1994-11-23 | Bayer Ag | Proteinaseninhibitoren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| US5278285A (en) * | 1990-02-01 | 1994-01-11 | Bayer Aktiengesellschaft | Variant of Kunitz-type inhibitor derived from the α3-chain of human type VI collagen produced by recombinant DNA technology |
-
1993
- 1993-01-06 IL IL104327A patent/IL104327A0/xx unknown
- 1993-01-07 RU RU94036776/13A patent/RU94036776A/ru unknown
- 1993-01-07 HU HU9401993A patent/HUT70292A/hu unknown
- 1993-01-07 AU AU33457/93A patent/AU671611B2/en not_active Ceased
- 1993-01-07 ZA ZA9398A patent/ZA9398B/xx unknown
- 1993-01-07 DE DE69310141T patent/DE69310141D1/de not_active Expired - Lifetime
- 1993-01-07 EP EP93902103A patent/EP0621869B1/en not_active Expired - Lifetime
- 1993-01-07 WO PCT/DK1993/000002 patent/WO1993014119A1/en not_active Application Discontinuation
- 1993-01-07 NZ NZ246567A patent/NZ246567A/en unknown
- 1993-01-07 CA CA002127248A patent/CA2127248A1/en not_active Abandoned
- 1993-01-07 AT AT93902103T patent/ATE152129T1/de not_active IP Right Cessation
- 1993-01-07 JP JP5511990A patent/JPH07506334A/ja active Pending
- 1993-01-07 CZ CZ941646A patent/CZ164694A3/cs unknown
-
1994
- 1994-07-06 FI FI943231A patent/FI943231A/fi unknown
- 1994-07-06 NO NO942552A patent/NO942552L/no unknown
- 1994-11-04 US US08/334,773 patent/US5629176A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CZ164694A3 (en) | 1994-12-15 |
| FI943231A0 (fi) | 1994-07-06 |
| ATE152129T1 (de) | 1997-05-15 |
| AU671611B2 (en) | 1996-09-05 |
| WO1993014119A1 (en) | 1993-07-22 |
| EP0621869B1 (en) | 1997-04-23 |
| RU94036776A (ru) | 1996-09-27 |
| CA2127248A1 (en) | 1993-07-22 |
| DE69310141D1 (de) | 1997-05-28 |
| FI943231A (fi) | 1994-07-06 |
| ZA9398B (en) | 1993-08-10 |
| HUT70292A (en) | 1995-09-28 |
| JPH07506334A (ja) | 1995-07-13 |
| EP0621869A1 (en) | 1994-11-02 |
| AU3345793A (en) | 1993-08-03 |
| IL104327A0 (en) | 1993-05-13 |
| HU9401993D0 (en) | 1994-09-28 |
| US5629176A (en) | 1997-05-13 |
| NZ246567A (en) | 1996-05-28 |
| NO942552D0 (no) | 1994-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO942552L (no) | Humanproteaseinhibitorvarianter av Kunitz-type | |
| NO942549L (no) | Humanproteaseinhibitorvariant av Kunitz-type | |
| NO942553L (no) | Ny humanproteaseinhibitor av Kunitz-type og varianter derav | |
| ATE154938T1 (de) | Inhibitorvariante der menschlichen protease vom kunitz-typ | |
| MX9706974A (es) | Endoglucanasas novedosas. | |
| HK1154211A1 (zh) | 預防和減少失血和炎症反應 | |
| PE7898A1 (es) | Peptidos compuestos que se ligan al receptor de trombopoietina | |
| DK0466175T3 (da) | Porcint CNP-gen og præcursor-protein | |
| MD1652F2 (en) | Protein possessing the cytokin - type activity, recombinant DNA-codifyer for such protein, transformed cells and microorganism, expression vector, process for protein obtaining and remedy containing such a protein | |
| AU5963290A (en) | Inhibition of the n-end rule pathway in living cells | |
| WO2006018418A3 (en) | Antiangiogenic peptides | |
| HK1080870A1 (en) | Chi-conotoxin peptides having a n-terminal pyroglutamic acid | |
| HUP9900789A2 (hu) | Lefelé irányuló szabályozásra rezisztens C3 konvertáz | |
| IL74703A0 (en) | Process for the low-racemization preparation of peptide intermediates of the synthesis of gonadorelin and gonadorelin analogs,and new intermediates for this process | |
| RU99116976A (ru) | Миелопептиды и их терапевтическое использование | |
| PT789761E (pt) | Scf humano, uma respectiva variante de processamento, sua utilizacao farmaceutica | |
| EP0687685A4 (en) | PHYSIOLOGICALLY ACTIVE PEPTIDES | |
| EP1225184A4 (en) | HUMAN ANTITHROMBIN VARIANTS | |
| ES2119746T3 (es) | Nuevo peptido fisiologicamente activo y agente regulador del metabolismo del calcio que comprende dicho peptido como ingrediente activo. | |
| FR2787454B1 (fr) | Inhibiteur de la topoisomerase ii | |
| TH1778A (th) | สารคล้ายคลึง จี อาร์ เอฟ (grf) | |
| ECSP961798A (es) | Peptidos de somatostatina | |
| ECSP951582A (es) | Analogos de insulina acilados | |
| TH57872B (th) | สารยับยั้งของอินทีกริน อัลฟานู เบตา6 | |
| RU94036770A (ru) | Домен ингибитора протеазы, днк, вектор, клетка, способ получения домена, фармацевтическая композиция, применение домена |